BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18555557)

  • 1. Immunohistochemical diagnosis of methylthioadenosine phosphorylase (MTAP) deficiency in non-small cell lung carcinoma.
    Watanabe F; Takao M; Inoue K; Nishioka J; Nobori T; Shiraishi T; Kaneda M; Sakai T; Yada I; Shimpo H
    Lung Cancer; 2009 Jan; 63(1):39-44. PubMed ID: 18555557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylthioadenosine phosphorylase deficiency in Japanese osteosarcoma patients.
    Miyazaki S; Nishioka J; Shiraishi T; Matsumine A; Uchida A; Nobori T
    Int J Oncol; 2007 Nov; 31(5):1069-76. PubMed ID: 17912432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC).
    Schmid M; Malicki D; Nobori T; Rosenbach MD; Campbell K; Carson DA; Carrera CJ
    Oncogene; 1998 Nov; 17(20):2669-75. PubMed ID: 9840931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and clinical significance of methylthioadenosine phosphorylase gene in patients with non-small cell lung cancer].
    Dai WM; Li BY; Yu CH; Chu XY; Zhang KT
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):907-9. PubMed ID: 15329275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylthioadenosine phosphorylase cDNA transfection alters sensitivity to depletion of purine and methionine in A549 lung cancer cells.
    Hori H; Tran P; Carrera CJ; Hori Y; Rosenbach MD; Carson DA; Nobori T
    Cancer Res; 1996 Dec; 56(24):5653-8. PubMed ID: 8971171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma.
    Hellerbrand C; Mühlbauer M; Wallner S; Schuierer M; Behrmann I; Bataille F; Weiss T; Schölmerich J; Bosserhoff AK
    Carcinogenesis; 2006 Jan; 27(1):64-72. PubMed ID: 16081515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylthioadenosine phosphorylase gene is silenced by promoter hypermethylation in human lymphoma cell line DHL-9: another mechanism of enzyme deficiency.
    Ishii M; Nakazawa K; Wada H; Nishioka J; Nakatani K; Yamada Y; Kamihira S; Kusunoki M; Nobori T
    Int J Oncol; 2005 Apr; 26(4):985-91. PubMed ID: 15753993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
    Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
    Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapy.
    Marcé S; Balagué O; Colomo L; Martinez A; Höller S; Villamor N; Bosch F; Ott G; Rosenwald A; Leoni L; Esteller M; Fraga MF; Montserrat E; Colomer D; Campo E
    Clin Cancer Res; 2006 Jun; 12(12):3754-61. PubMed ID: 16778103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylthioadenosine phosphorylase deficiency in human non-small cell lung cancers.
    Nobori T; Szinai I; Amox D; Parker B; Olopade OI; Buchhagen DL; Carson DA
    Cancer Res; 1993 Mar; 53(5):1098-101. PubMed ID: 8382555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy targeting methylthioadenosine phosphorylase (MTAP) deficiency in adult T cell leukemia (ATL).
    Harasawa H; Yamada Y; Kudoh M; Sugahara K; Soda H; Hirakata Y; Sasaki H; Ikeda S; Matsuo T; Tomonaga M; Nobori T; Kamihira S
    Leukemia; 2002 Sep; 16(9):1799-807. PubMed ID: 12200696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy.
    Chen ZH; Zhang H; Savarese TM
    Cancer Res; 1996 Mar; 56(5):1083-90. PubMed ID: 8640765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of methylthioadenosine phosphorylase (MTAP) gene and demethylation of its promoter in human colorectal cancer].
    Dou JX; Zhang WD; Li WT; Li HL; Cai XS; Liu J
    Ai Zheng; 2009 Apr; 28(4):390-4. PubMed ID: 19622299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.
    García-Castellano JM; Villanueva A; Healey JH; Sowers R; Cordon-Cardo C; Huvos A; Bertino JR; Meyers P; Gorlick R
    Clin Cancer Res; 2002 Mar; 8(3):782-7. PubMed ID: 11895909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter methylation primarily occurs in tumor cells of patients with non-small cell lung cancer.
    De Jong WK; Verpooten GF; Kramer H; Louwagie J; Groen HJ
    Anticancer Res; 2009 Jan; 29(1):363-9. PubMed ID: 19331174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomas.
    Zimling ZG; Jørgensen A; Santoni-Rugiu E
    Histopathology; 2012 May; 60(6B):E96-105. PubMed ID: 22394205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
    Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
    Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer.
    Liu Z; Zhao J; Chen XF; Li W; Liu R; Lei Z; Liu X; Peng X; Xu K; Chen J; Liu H; Zhou QH; Zhang HT
    Lung Cancer; 2008 Oct; 62(1):15-22. PubMed ID: 18358560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing abnormal gene promoter methylation in paraffin-embedded sputum from patients with NSCLC.
    Olaussen KA; Soria JC; Park YW; Kim HJ; Kim SH; Ro JY; André F; Jang SJ
    Eur J Cancer; 2005 Sep; 41(14):2112-9. PubMed ID: 16129599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma.
    Behrmann I; Wallner S; Komyod W; Heinrich PC; Schuierer M; Buettner R; Bosserhoff AK
    Am J Pathol; 2003 Aug; 163(2):683-90. PubMed ID: 12875987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.